Remove 2011 Remove Leadership Remove Life Science
article thumbnail

Merative formerly IBM Watson Health poised to launch raft of new products in 2025

Lloyd Price

The new company aims to leverage its extensive data sets and technology to provide innovative solutions across various healthcare sectors, including life sciences, provider, imaging, health plan, employer, and government health and human services. In 2011, the Jeopardy!-winning

article thumbnail

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

Believes Nymox Management and Board Must Be Held Accountable for Prolonged Underperformance and Egregious Governance Practices Urges Shareholders to Vote on the WHITE Proxy Card to Install New Leadership and a New Board at Upcoming Special Meeting CARSON CITY, Nev. & in 2011 and $5.00 in 2017 to as low as $0.19 on June 30, 2023.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Aspects of Social Determinants of Health: Collecting Data

Healthcare IT Today

The other appeals to researchers in the life sciences and clinical settings. Hands-On Data Collection I talked to Dr. Geoff Rutledge, chief medical officer of HealthTap , a company that came early to telehealth and that I covered several times as far back as 2011.

article thumbnail

Healthcare has never experienced anything like Amazon’s combination of logistics, voice AI expertise and data analytics. The impact could be huge.

Lloyd Price

If you consider its leadership team (led by surgeon and best-selling writer Atul Gawande) and Amazon’s yearslong gesturing toward healthcare and previous comments by Berkshire Hathaway founder Warren Buffett, some clues come into focus. KPMG’s Shehata views Haven’s leadership hirings as proof that it’s taking data concerns seriously.

Nursing 40
article thumbnail

StoryCatch Partners Acquires EmpiraMed

Healthcare IT Today

EmpiraMed performs post-market, prospective, virtual clinical studies to generate real-world evidence for life sciences, pioneering site-less virtual studies. She brings a strong leadership background as the founder of Isleworth Group, as a former deal professional at Bain Capital, and Partner at Parthenon Capital.